This is the authors' abstract. We don't add key points for this paper.
Colorectal cancer (CRC) is the third diagnosed cancer worldwide. The 44% of metastatic colorectal cancer patients were diagnosed at an early stage. Despite curative resection, approximately 40% of patients will develop metastases within few years. Previous studies indicate the presence of cancer stem cells (CSCs) and their contribute to CRC progression and metastasis. miRNAs deregulation plays a role in CSCs formation and in tumor development. At the light of previous studies, we investigated the role of miR-486-5p to better understand its role in CSC. The expression of miR-486-5p was assessed in adherent cells and spheres generated from two CRC cell lines to observe the difference of expression in CSC-enriched spheroids. After, we overexpressed and underexpressed this miRNA in adherent and spheres cultures through the transfection of miR-486-5p mimic and a mimic inhibitor. The results demonstrated that miR-486-5p exhibited a notable downregulation in CSC models, and its over-expression led to a significant decrease in colony size. In this study, we confirmed that miR-486-5p plays an onco-suppressive role in CRC, thereby advancing our understanding of the role of this microRNA in the CSC phenotype.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Etzi et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: